Brain tumors in individuals with Familial Adenomatous Polyposis: A cancer registry experience and pooled case report analysis

Thomas M. Attard, Pierre Giglio, Sireesha Koppula, Carrie Snyder, Henry T. Lynch

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

BACKGROUND. Most individuals with Familial Adenomatous Polyposis (FAP) harbor mutations in the APC gene on chromosome 5q21. They are at an increased risk of brain tumors, including cerebellar medulloblastoma, when compared with the general population (Brain Tumor Polyposis - BTP Type 2). Genotype-phenotype correlations between APC gene mutations and central nervous system (CNS) tumors have, thus far not been successful. Herein the authors have pooled their registry experience in BTP type 2 with the published reports. METHODS. The authors analyzed their established hereditary CRC Registry for brain tumors in FAP pedigrees (56 families, 213 individuals), pooled their patients with BTP and known APC mutations with those reported thus far elsewhere, and compared the resulting mutation distribution of FAP-BTP with the mutation distribution for APC mutations in the US. RESULTS. Twenty-eight patients from 24 families were accrued, the most common brain tumor in BTP was medulloblastoma (60%) predominantly in females (12:5) under the age of 20 (mean age 14.7 SD 9.2). Other histologic subtypes included astrocytoma and ependymoma. Analysis of the pooled APC mutation data by Chi-square test of association shows an odds ratio of 3.7 (P <.005) for all brain tumor subtypes and 13.1 (P <.001) for medulloblastoma in patients harboring segment 2 APC mutation (codons 679-1224) compared to nonsegment 2 mutation. CONCLUSIONS. In patients with FAP and identifiable APC gene mutation, CNS tumors, especially medulloblastoma which developed in most cases during childhood, are more common in females with FAP and APC gene mutation in codons 686-1217. Further studies are necessary to determine if this observation and the natural history of medulloblastoma in children justifies novel, aggressive, targeted screening of at - risk individuals.

Original languageEnglish
Pages (from-to)761-766
Number of pages6
JournalCancer
Volume109
Issue number4
DOIs
StatePublished - Feb 15 2007

Fingerprint

Adenomatous Polyposis Coli
Brain Neoplasms
Registries
Mutation
Medulloblastoma
APC Genes
Neoplasms
Central Nervous System Neoplasms
Codon
Ependymoma
Astrocytoma
Genetic Association Studies
Chi-Square Distribution
Pedigree
Chromosomes
Odds Ratio

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Brain tumors in individuals with Familial Adenomatous Polyposis : A cancer registry experience and pooled case report analysis. / Attard, Thomas M.; Giglio, Pierre; Koppula, Sireesha; Snyder, Carrie; Lynch, Henry T.

In: Cancer, Vol. 109, No. 4, 15.02.2007, p. 761-766.

Research output: Contribution to journalArticle

Attard, Thomas M. ; Giglio, Pierre ; Koppula, Sireesha ; Snyder, Carrie ; Lynch, Henry T. / Brain tumors in individuals with Familial Adenomatous Polyposis : A cancer registry experience and pooled case report analysis. In: Cancer. 2007 ; Vol. 109, No. 4. pp. 761-766.
@article{52bad5d3b8e94d9aa9780341deee187b,
title = "Brain tumors in individuals with Familial Adenomatous Polyposis: A cancer registry experience and pooled case report analysis",
abstract = "BACKGROUND. Most individuals with Familial Adenomatous Polyposis (FAP) harbor mutations in the APC gene on chromosome 5q21. They are at an increased risk of brain tumors, including cerebellar medulloblastoma, when compared with the general population (Brain Tumor Polyposis - BTP Type 2). Genotype-phenotype correlations between APC gene mutations and central nervous system (CNS) tumors have, thus far not been successful. Herein the authors have pooled their registry experience in BTP type 2 with the published reports. METHODS. The authors analyzed their established hereditary CRC Registry for brain tumors in FAP pedigrees (56 families, 213 individuals), pooled their patients with BTP and known APC mutations with those reported thus far elsewhere, and compared the resulting mutation distribution of FAP-BTP with the mutation distribution for APC mutations in the US. RESULTS. Twenty-eight patients from 24 families were accrued, the most common brain tumor in BTP was medulloblastoma (60{\%}) predominantly in females (12:5) under the age of 20 (mean age 14.7 SD 9.2). Other histologic subtypes included astrocytoma and ependymoma. Analysis of the pooled APC mutation data by Chi-square test of association shows an odds ratio of 3.7 (P <.005) for all brain tumor subtypes and 13.1 (P <.001) for medulloblastoma in patients harboring segment 2 APC mutation (codons 679-1224) compared to nonsegment 2 mutation. CONCLUSIONS. In patients with FAP and identifiable APC gene mutation, CNS tumors, especially medulloblastoma which developed in most cases during childhood, are more common in females with FAP and APC gene mutation in codons 686-1217. Further studies are necessary to determine if this observation and the natural history of medulloblastoma in children justifies novel, aggressive, targeted screening of at - risk individuals.",
author = "Attard, {Thomas M.} and Pierre Giglio and Sireesha Koppula and Carrie Snyder and Lynch, {Henry T.}",
year = "2007",
month = "2",
day = "15",
doi = "10.1002/cncr.22475",
language = "English",
volume = "109",
pages = "761--766",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Brain tumors in individuals with Familial Adenomatous Polyposis

T2 - A cancer registry experience and pooled case report analysis

AU - Attard, Thomas M.

AU - Giglio, Pierre

AU - Koppula, Sireesha

AU - Snyder, Carrie

AU - Lynch, Henry T.

PY - 2007/2/15

Y1 - 2007/2/15

N2 - BACKGROUND. Most individuals with Familial Adenomatous Polyposis (FAP) harbor mutations in the APC gene on chromosome 5q21. They are at an increased risk of brain tumors, including cerebellar medulloblastoma, when compared with the general population (Brain Tumor Polyposis - BTP Type 2). Genotype-phenotype correlations between APC gene mutations and central nervous system (CNS) tumors have, thus far not been successful. Herein the authors have pooled their registry experience in BTP type 2 with the published reports. METHODS. The authors analyzed their established hereditary CRC Registry for brain tumors in FAP pedigrees (56 families, 213 individuals), pooled their patients with BTP and known APC mutations with those reported thus far elsewhere, and compared the resulting mutation distribution of FAP-BTP with the mutation distribution for APC mutations in the US. RESULTS. Twenty-eight patients from 24 families were accrued, the most common brain tumor in BTP was medulloblastoma (60%) predominantly in females (12:5) under the age of 20 (mean age 14.7 SD 9.2). Other histologic subtypes included astrocytoma and ependymoma. Analysis of the pooled APC mutation data by Chi-square test of association shows an odds ratio of 3.7 (P <.005) for all brain tumor subtypes and 13.1 (P <.001) for medulloblastoma in patients harboring segment 2 APC mutation (codons 679-1224) compared to nonsegment 2 mutation. CONCLUSIONS. In patients with FAP and identifiable APC gene mutation, CNS tumors, especially medulloblastoma which developed in most cases during childhood, are more common in females with FAP and APC gene mutation in codons 686-1217. Further studies are necessary to determine if this observation and the natural history of medulloblastoma in children justifies novel, aggressive, targeted screening of at - risk individuals.

AB - BACKGROUND. Most individuals with Familial Adenomatous Polyposis (FAP) harbor mutations in the APC gene on chromosome 5q21. They are at an increased risk of brain tumors, including cerebellar medulloblastoma, when compared with the general population (Brain Tumor Polyposis - BTP Type 2). Genotype-phenotype correlations between APC gene mutations and central nervous system (CNS) tumors have, thus far not been successful. Herein the authors have pooled their registry experience in BTP type 2 with the published reports. METHODS. The authors analyzed their established hereditary CRC Registry for brain tumors in FAP pedigrees (56 families, 213 individuals), pooled their patients with BTP and known APC mutations with those reported thus far elsewhere, and compared the resulting mutation distribution of FAP-BTP with the mutation distribution for APC mutations in the US. RESULTS. Twenty-eight patients from 24 families were accrued, the most common brain tumor in BTP was medulloblastoma (60%) predominantly in females (12:5) under the age of 20 (mean age 14.7 SD 9.2). Other histologic subtypes included astrocytoma and ependymoma. Analysis of the pooled APC mutation data by Chi-square test of association shows an odds ratio of 3.7 (P <.005) for all brain tumor subtypes and 13.1 (P <.001) for medulloblastoma in patients harboring segment 2 APC mutation (codons 679-1224) compared to nonsegment 2 mutation. CONCLUSIONS. In patients with FAP and identifiable APC gene mutation, CNS tumors, especially medulloblastoma which developed in most cases during childhood, are more common in females with FAP and APC gene mutation in codons 686-1217. Further studies are necessary to determine if this observation and the natural history of medulloblastoma in children justifies novel, aggressive, targeted screening of at - risk individuals.

UR - http://www.scopus.com/inward/record.url?scp=33846896438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846896438&partnerID=8YFLogxK

U2 - 10.1002/cncr.22475

DO - 10.1002/cncr.22475

M3 - Article

C2 - 17238184

AN - SCOPUS:33846896438

VL - 109

SP - 761

EP - 766

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -